Copyright © 2003 by the European Society of Cardiology.
Editorial
How should we analyse hospitalizations in clinical trials?
1 University of Bergen, Cardiology Division, Central Hospital in Rogaland, Stravanger, Norway
2 Merck Research Laboratories, West Point, PA, USA
| The first 10% of the full text of this article appears below. |
See doi:10.1016/S1095-668X(02)00384-6for the article to which this editorial refers.
Heart failure is the fourth leading cause of hospitalization in the United States and the most frequent cause in the population over 65 years of age.1 Due to the rising prevalence of heart failure in the aging population, morbidity and mortality from this disease is increasing in epidemic proportions.2 While it is impossible to measure perfectly the burden of heart failure on patients, their families and society, both the acute and chronic symptoms of heart failure eventually translate into increased hospitalization time.3 Admission to hospital due to
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- The use of hospital admission data as a measure of outcome in clinical studies of heart failure
- C Metcalfe, S.G Thompson, M.R Cowie, and L.D Sharples
EHJ 2003 24: 105-112.[Abstract] [FREE Full Text]
This article has been cited by other articles:
![]() |
R. Roccaforte, C. Demers, F. Baldassarre, K. K.Teo, and S. Yusuf Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis Eur J Heart Fail, December 1, 2005; 7(7): 1133 - 1144. [Abstract] [Full Text] [PDF] |
||||
